MBX
MBX Biosciences Inc.

415
Mkt Cap
$1.82B
Volume
67,051.00
52W High
$44.89
52W Low
$4.81
PE Ratio
-16.93
MBX Fundamentals
Price
$42.32
Prev Close
$40.53
Open
$39.77
50D MA
$30.35
Beta
1.67
Avg. Volume
867,563.50
EPS (Annual)
-$1.85
P/B
4.68
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
MBX Biosciences (NASDAQ:MBX) Trading 7.6% Higher - Time to Buy?
MBX Biosciences (NASDAQ:MBX) Stock Price Up 7.6% - Time to Buy...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
MBX Biosciences (NASDAQ:MBX) Trading Down 8.4% - Here's Why
MBX Biosciences (NASDAQ:MBX) Shares Down 8.4% - Time to Sell...
MarketBeat·15d ago
News Placeholder
MBX Biosciences (NASDAQ:MBX) Stock Price Down 5.8% - Here's What Happened
MBX Biosciences (NASDAQ:MBX) Stock Price Down 5.8% - Should You Sell...
MarketBeat·25d ago
News Placeholder
MBX Biosciences (NASDAQ:MBX) Reaches New 12-Month High - Still a Buy?
MBX Biosciences (NASDAQ:MBX) Hits New 12-Month High - What's Next...
MarketBeat·28d ago
News Placeholder
MBX Biosciences (NASDAQ:MBX) Stock Price Up 10.8% - Still a Buy?
MBX Biosciences (NASDAQ:MBX) Stock Price Up 10.8% - What's Next...
MarketBeat·29d ago
News Placeholder
MBX Biosciences (NASDAQ:MBX) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of MBX Biosciences from a "sell" rating to a "hold" rating in a research note on Sunday...
MarketBeat·1mo ago
News Placeholder
EcoR1 Capital LLC Lowers Holdings in MBX Biosciences, Inc. $MBX
EcoR1 Capital LLC trimmed its holdings in MBX Biosciences, Inc. (NASDAQ:MBX - Free Report) by 8.7% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission...
MarketBeat·1mo ago
News Placeholder
MBX Biosciences (NASDAQ:MBX) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut MBX Biosciences from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·1mo ago
News Placeholder
Walleye Capital LLC Increases Stock Holdings in MBX Biosciences, Inc. $MBX
Walleye Capital LLC grew its stake in MBX Biosciences, Inc. (NASDAQ:MBX - Free Report) by 116.5% during the second quarter, according to the company in its most recent disclosure with the Securities...
MarketBeat·1mo ago
News Placeholder
MBX Biosciences, Inc. $MBX Stake Increased by Stempoint Capital LP
Stempoint Capital LP lifted its stake in MBX Biosciences, Inc. (NASDAQ:MBX - Free Report) by 46.0% in the second quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·1mo ago
<
1
2
...
>

Latest MBX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.